Cristina P. Rodriguez, Sylvia Lee, Graham Watson, Amanda Lynn Gillespie-Twardy, Douglas Earl Laux, Patrick J. Ward, Jeffrey Yorio, Omar Khaled Abughanimeh, J. Thaddeus Beck, Kevin Kim, Hailing Lu, Jason Berndt, Marya F. Chaney, Eeman Shaikh, Erin R. Alesi. "Phase 2 open-label study of brentuximab vedotin (BV) + pembrolizumab (pembro) in patients (pts) with treatment (tx)-naive metastatic head and neck squamous cell carcinoma (HNSCC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.6015